Riskpilot← Back to searchSign inGet full accessMeliora Medtech AB
ABActiveOrg 5568669245Grimboåsen 5 4 TrActivities of agents involved in the wholesale of other particular products · NACE 4618Est. 20117 employees
Revenue 2024
SEK 30,3M
-50% vs 2023
EBITDA margin
9.2%
-54% vs 2023
Equity ratio
40.6%
Financial strength
Net profit 2024
SEK 2,1M
-56% vs 2023
| Revenue | SEK 30,3M | -50% |
| EBITDA | SEK 2,8M | -54% |
| Net profit | SEK 2,1M | -56% |
| Total assets | SEK 10,3M | -51% |
| Equity | SEK 4,2M | -67% |
| Employees | 7 | — |
Legal name
Meliora Medtech AB
Org number
5568669245
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
7 oktober 2011
Share capital
SEK 50 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Registrerad kvalificerad revisor saknas.
Company purpose
Import av Medicinteknik, försäljning till sjukhus.
Address
Grimboåsen 5 4 Tr
Email
customerservice@melioramedtech.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 21 872 | 33 015 | 46 122 | 60 974 | 30 344 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 001 | 3 195 | 6 935 | 6 049 | 2 784 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 4 001 | 3 195 | 6 935 | 6 049 | 2 784 |
| Net financials | −475 | 343 | −270 | −68 | −111 |
| Profit before tax | 3 526 | 3 538 | 6 665 | 5 982 | 2 672 |
| Tax | −769 | −753 | −1 399 | −1 274 | −617 |
| Net profit | 2 757 | 2 785 | 5 266 | 4 708 | 2 055 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 978 | 10 306 | 19 007 | 21 070 | 10 277 |
| Equity | 5 286 | 5 130 | 9 447 | 12 794 | 4 172 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 693 | 5 176 | 9 560 | 8 276 | 6 105 |
| Total debt | 2 693 | 5 176 | 9 560 | 8 276 | 6 105 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
40.6%
This company
38.2%
Market median
+6% vs market
20202024
Return on equity
49.3%
This company
18.4%
Market median
+168% vs market
20202024
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20202024
Asset turnover
2.95×
This company
1.12×
Market median
+163% vs market
20202024
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
MF | Audit | 2020 |
| Former (1) | ||
LM Audit | Audit | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Meliora Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Anders Henrik Nyman | Deputy Chief Executive Officer | 0 companies |
| Mats Fredrik Johansson | Audit | 0 companies |
| Lars Mikael Thorsson | Audit | 0 companies |
| Carina Magdalena Nyman | Deputy Board Member | 0 companies |
| Petra Linnea Bachmann | Deputy Board Member | 0 companies |
| Daniel Lennart Karlsson | Chairman | 0 companies |